Equities

Medius Holdings Co Ltd

3154:TYO

Medius Holdings Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)837.00
  • Today's Change-3.00 / -0.36%
  • Shares traded17.80k
  • 1 Year change+1.33%
  • Beta0.6076
Data delayed at least 20 minutes, as of May 21 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

MEDIUS HOLDINGS Co., Ltd. is a Japan-based company mainly engaged in the sale and maintenance of medical equipment, as well as the sale and rental of nursing care equipment. The Company operates through two business segments. The Medical Equipment Sales segment sells medical equipment to domestic healthcare facilities, such as hospitals. The Care and Welfare business segment is engaged in sales and rental of nursing care equipment purchased from Japanese nursing and welfare equipment manufacturers, agents, trading companies, to medical institutions such as domestic hospitals and general individuals. In addition, the Company is also engaged in sales of nursing care and welfare equipment purchased from domestic and foreign manufacturers to medical institutions such as hospitals and medical material dealers.

  • Revenue in JPY (TTM)250.78bn
  • Net income in JPY847.94m
  • Incorporated2009
  • Employees2.29k
  • Location
    Medius Holdings Co LtdToho Hibiya Bldg., 1-2-2, Yuraku-choCHIYODA-KU 100-0006JapanJPN
  • Phone+81 368112958
  • Fax+81 368111261
  • Websitehttps://www.medius.co.jp/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
3154:TYO since
announced
Transaction
value
Makoto Medical SystemsAnnounced21 Feb 202421 Feb 2024Announced12.80%1.07m
Makoto Medical SystemsDeal completed24 Oct 202324 Oct 2023Deal completed19.06%2.04m
Data delayed at least 20 minutes, as of May 21 2024 07:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
DVx Inc45.85bn172.91m10.82bn319.0060.461.1417.890.23616.6116.614,394.81880.721.9826.604.02--0.74743.111.777.5710.3911.600.37711.491.51--0.001447.57-3.442.57-81.53-29.2311.2315.81
JMS Co Ltd65.29bn-36.00m13.33bn5.65k--0.32524.740.2042-1.49-1.492,668.181,657.260.82072.784.07---0.05781.33-0.08651.9721.5924.29-0.07051.570.987--0.397943.412.432.38-112.81---2.421.22
OLBA Healthcare Holdings Inc117.02bn1.50bn13.68bn1.32k8.741.2010.780.1169250.44250.4419,539.551,826.782.6616.204.3288,854,800.003.402.7112.139.7811.5811.061.280.91740.9764152.760.162732.162.330.5165-7.896.06-6.4211.84
Techno Medica Co Ltd10.28bn1.35bn15.45bn225.009.720.882521.191.50181.53181.531,319.311,998.920.55772.552.65--7.316.688.787.8050.1048.8613.1112.313.85----39.339.781.9617.154.190.71687.67
Japan Medical Dynamic Marketing, INC.23.18bn1.27bn16.87bn488.0013.190.65765.810.727648.3048.30880.53968.740.76090.68154.15--4.296.514.927.5363.6966.975.638.882.11--0.055218.268.786.74-10.68-8.52-2.959.24
HOSHI IRYO-SANKI CO., LTD14.78bn1.39bn17.37bn470.0011.360.92737.511.18447.23447.234,742.975,478.130.667434.485.35--6.375.668.077.1948.7849.049.558.652.86--0.045815.747.256.4211.159.87-13.238.45
Daiken Medical Co Ltd9.75bn988.60m17.48bn188.0015.952.2514.531.7934.4134.41339.39244.440.88563.914.03--8.987.4412.9110.8440.8441.7410.149.281.58752.550.23171.356.713.0138.843.03-4.010.9806
Seed Co Ltd32.40bn1.96bn17.71bn974.007.601.023.690.546576.9476.941,276.55573.500.72332.657.48--4.381.997.533.5143.7842.316.062.740.8037--0.578139.565.891.90721.4415.3020.424.56
Medius Holdings Co Ltd250.78bn847.94m18.60bn2.29k21.810.93647.160.074238.5138.5111,407.31897.032.2717.994.25109,607,600.000.76731.643.176.0212.0511.490.33810.58370.899338.740.565731.155.497.29-19.8015.0942.529.46
Japan Tissue Engineering Co., Ltd.2.51bn143.17m24.85bn215.00173.594.0989.659.893.533.5361.91149.730.36253.534.26--2.06-4.722.37-5.3167.2457.305.69-16.385.85996.59----23.701.29119.63--30.22--
Cyberdyne Inc4.35bn-1.48bn26.53bn257.00--0.9999--6.09-7.00-7.0020.62193.020.08691.977.17---3.29-1.14-3.36-1.1654.9561.14-37.88-20.6814.14--0.0154--32.3820.57-395.30---22.40--
Data as of May 21 2024. Currency figures normalised to Medius Holdings Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

4.61%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 30 Apr 2024377.60k1.71%
Nikko Asset Management Co., Ltd.as of 10 May 2024182.50k0.82%
Daiwa Asset Management Co. Ltd.as of 29 Mar 2024172.20k0.78%
Dimensional Fund Advisors LPas of 09 May 2024127.80k0.58%
Mitsubishi UFJ Asset Management Co., Ltd.as of 10 May 202475.70k0.34%
BlackRock Japan Co. Ltd.as of 09 May 202420.10k0.09%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 20 Apr 202319.60k0.09%
Asset Management One Co., Ltd.as of 09 May 202419.20k0.09%
Dimensional Fund Advisors Ltd.as of 29 Feb 202417.25k0.08%
Sumitomo Mitsui DS Asset Management Co., Ltd.as of 09 May 20248.10k0.04%
More ▼
Data from 31 Mar 2024 - 16 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.